Drug Trial Radar · NCT05597098
Investigation of the Distinct Mechanisms Involved in Inflammatory Resolution Between Healthy Men and Women
Last checked: Nov 19, 2026Latest source record: Jul 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
34
Planned (sponsor's estimate)
Start
Dec 12, 2022
Primary completion
Dec 12, 2027
Study completion Dec 12, 2027
Sponsor
- Lead sponsor
- Queen Mary University of LondonAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 27, 2022
Design
- Study type
- Interventional
- Phase
- Early phase 1
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Basic science
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Important differences exist between sexes in incidence, disease patterns and outcomes in coronary artery disease that is not well understood. It is likely that key differences in the underlying biological mechanism, in particular in inflammatory responses, play a part in underpinning these differences. Previous evidence demonstrates that healthy females appear to be more adept at resolving inflammation compared to healthy males. Since inflammation is thought to be a key initiating phenomenon in coronary artery disease the investigators will examine the differences in inflammatory resolution between the sexes in healthy volunteers.
Conditions
- Inflammation
Interventions
CantharidinDrug
0.1% cantharidin solution in acetone from 0.7% stock solution of cantharone is prepared and applied immediately. 10 μl of cantharidin per disc.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Comparison of the presence or not of blister at each timepoint over 24-72h between the sexesTime frame: 24 hours, 48 hours, 72 hours
- Comparison of blister volume at each timepoint over 24-72h between the sexesTime frame: 24 hours, 48 hours, 72 hours
- Comparison of blister cell number at each timepoint over 24-72 hours between the sexesTime frame: 24 hours, 48 hours, 72 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The William Harvey Research Institute
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.